Bottom line
DUSL vs PILL: the short answer
DUSL (Direxion Daily Industrials Bull 3X ETF) and PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) are quite different portfolios: only about 33% of their top holdings (by weight) are shared.
DUSL is cheaper at 0.97% vs 0.98% — a difference of $1.00 a year per $10,000 invested.
Over five years, DUSL returned +22.8% a year vs −12.6% for PILL.
Updated Nov 19, 2026
DUSL vs PILL side by side
| DUSL | PILL | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.97% | 0.98% |
| Annual cost per $10k | $97 | $98 |
| 10-yr cost on $10k (prospectus) | $1,200 | $1,456 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +36.8% | +75.0% |
| 5-yr return (annualized) | +22.8% | −12.6% |
| 10-yr return (annualized) | — | — |
| Best quarter | +59.2% | +103.7% |
| Worst quarter | −72.0% | −61.4% |
| Net assets (fund) | $56.5M | $20.7M |
| Number of holdings | 90 | 73 |
| Portfolio turnover | 44% | 88% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | DUSL | PILL | Difference |
|---|---|---|---|
| 2025 | +36.8% | +75.0% | −38.3% |
| 2024 | +34.8% | −6.9% | +41.8% |
| 2023 | +36.8% | −12.7% | +49.4% |
| 2022 | −31.0% | −43.1% | +12.1% |
| 2021 | +60.8% | −37.2% | +97.9% |
| 2020 | −20.2% | −0.3% | −19.9% |
| 2019 | +87.7% | +18.2% | +69.6% |
| 2018 | −44.9% | −19.6% | −25.3% |
Source: Fund prospectus bar charts
Holdings overlap
8 of DUSL's top 25 holdings also appear in PILL's top 25.
| Holding | DUSL | PILL |
|---|---|---|
| Goldman Financial | 18.28% | 22.36% |
| N/a | 5.46% | 7.41% |
| N/a | 4.68% | 7.41% |
| Dreyfus | 4.54% | 8.14% |
| N/a | 3.50% | 7.41% |
| N/a | 2.96% | 7.41% |
| N/a | 2.77% | 7.41% |
| Goldman Sachs Liq Es Fd A | 2.06% | 2.03% |
Source: SEC Form N-PORT
DUSL top 10
- Goldman Financial — 18.28%
- N/a — 5.46%
- General Electric Co — 4.92%
- Caterpillar Inc — 4.91%
- N/a — 4.68%
- Dreyfus — 4.54%
- Rtx Corp — 3.79%
- N/a — 3.50%
- Ge Vernova Inc — 3.48%
- N/a — 2.96%
PILL top 10
- Goldman Financial — 22.36%
- N/a — 16.36%
- Dreyfus — 8.14%
- N/a — 7.41%
- Crinetics Pharmaceuticals In — 2.77%
- Mbx Biosciences Inc — 2.42%
- Ataibeckley Inc — 2.16%
- Definium Therapeutics, Inc — 2.13%
- Goldman Sachs Liq Es Fd A — 2.03%
- Amylyx Pharmaceuticals Inc — 1.72%
FAQ
What is the difference between DUSL and PILL?
Which is cheaper, DUSL or PILL?
Should I own both DUSL and PILL?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.